• Health & Medicine

Lung cancer risks becoming ‘forgotten disease’ of the coronavirus pandemic  

At least 14,000 fewer people have been urgently referred for lung cancer tests since March.  At least 14,000 fewer people have been urgently referred for lung cancer tests since March. 

17 September 2020

• Health & Medicine

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

11 September 2020

• Health & Medicine

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant. Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

10 September 2020

• Health & Medicine

Rare bowel cancer treatment combo gets initial no for NHS use in England  

A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence. A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.

4 September 2020

• Health & Medicine

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England 

The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma. The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.

20 August 2020

• Health & Medicine

One third of cancer patients say coronavirus has impacted their treatment

One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results. One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results.

28 July 2020

• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Health & Medicine
• Policy & Insight

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic. Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

8 July 2020

• Health & Medicine

Prostate cancer hormone therapy not recommended for NHS in England

A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.

26 June 2020

• Charity News

£150 million per year could be cut from cancer research, warns charity

Cancer Research UK could be forced to cut £150 million per year from its research funding as the COVID-19 pandemic decimates its income. Cancer Research UK could be forced to cut £150 million per year from its research funding as the COVID-19 pandemic decimates its income.

24 June 2020

• Health & Medicine
• Policy & Insight

Getting cancer services back on track during the coronavirus pandemic

Cancer services are beginning to get up and running across the country, but we’re still a long way from either restoring capacity or addressing the backlog of people waiting for tests and treatment. Cancer services are beginning to get up and running across the country, but we’re still a long way from either restoring capacity or addressing the backlog of people waiting for tests and treatment.

22 June 2020

• Health & Medicine
• For Researchers

We stand in solidarity with our Black research community

Our statement against systemic racism and commitment to confront racial discrimination in our research activities. Our statement against systemic racism and commitment to confront racial discrimination in our research activities.

18 June 2020